CBIO
Crescent Biopharma
CBIO
CBIO
48 hedge funds and large institutions have $131M invested in Crescent Biopharma in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
48
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$375K | |
| 2 | +$370K | |
| 3 | +$199K | |
| 4 |
Renaissance Technologies
New York
|
+$139K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$118K |
Top Sellers
| 1 | -$639K | |
| 2 | -$400K | |
| 3 | -$204K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$198K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$174K |